Print this page

Executive Board 

Members of the Executive Board of Merck KGaA

Notes on memberships of statutory supervisory boards and comparable German and foreign supervisory bodies

(section 285 sentence 1, No. 10 HGB in conjunction with section 125 (1) sentence 5 AktG)

Members of the Executive Board of Merck KGaA

 

XLS

 

 

 

 

Memberships of

Member

(a)
(b)

other statutory supervisory boards and
comparable German and foreign supervisory bodies of corporations

Dr. Karl-Ludwig Kley
Darmstadt
Chairman

(a)

– Bertelsmann AG, Gütersloh
– BMW AG, Munich (Vice Chairman since May 18, 2010)
– 1. FC Köln GmbH & Co KGaA, Cologne (Chairman)

Dr. Michael Becker
Darmstadt

(b)

– Bâloise Holding AG, Basel, Switzerland (since April 23, 2010)
 

Dr. Bernd Reckmann
Seeheim-Jugenheim

(b)

– Millipore Corp., Billerica, USA (since July 2010)
– Millipore Corp., Cidra, Puerto Rico (since July 2010)

Elmar Schnee
Darmstadt

(b)

Member of the Board of Directors:
– ChemGenex Pharmaceuticals Ltd., Geelong, Australia
– Merck Serono S.A., Coinsins, Switzerland

Dr. Stefan Oschmann
Munich (as of Jan. 1, 2011)

no board positions

The general partners with no equity interest (Executive Board) manage the business activities in accordance with the laws, the Articles of Association and the rules of procedure. They are appointed by E. Merck KG with the consent of a simple majority of the other general partners. The members of the Executive Board are jointly responsible for the entire management of the company. The Executive Board is responsible for preparing the annual financial statements of Merck KGaA, the quarterly and half-year financial statements, as well as the annual financial statements of the Merck Group. In addition, the Executive Board ensures that all provisions of law, official regulations and the company’s internal policies are abided by, and works to achieve their compliance by all the companies of the Merck Group.

The Executive Board provides the Supervisory Board with regular, up-to-date and comprehensive reports about all company-relevant issues concerning planning, business developments, the risk situation and risk management. A Supervisory Board resolution regulates further details on the information and reporting duties of the Executive Board vis-à-vis the Supervisory Board. The Executive Board informs the Board of Partners and the Supervisory Board at least quarterly of the progress of business and the situation of the company. In addition, the Executive Board informs the stated boards at least annually of the company’s annual plans and strategic considerations.

The Executive Board passes its resolutions in meetings that are normally held twice a month.

© Merck KGaA, Darmstadt, Germany, Last Update 2010/02/23